Pure red cell aplasia associated with good's syndrome accompanied by decreased stem cell factor production in the bone marrow

Internal Medicine

Volumn 49, Issue 5, 2010, Pages 377-382

  Kuribayashi, Kageaki ^a   Fujimi, Akihito ^a   Kobune, Masayoshi ^a   Takimoto, Rishu ^a   Kikuchi, Shohei ^a   Iyama, Satoshi ^a   Kato, Junji ^a   Niitsu, Yoshiro ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclosporine A; Good's syndrome; Hypogammaglobulinemia; Pure red cell aplasia; Stem cell factor; Thymoma

Indexed keywords

CYCLOSPORIN A; CYTOKINE; FERRITIN; HYDROCORTISONE; IRON; LAMIVUDINE; MESSENGER RNA; STEM CELL FACTOR; VIRUS DNA;

AGED; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; BURST FORMING UNIT E; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROPOIESIS; FEMALE; GOOD SYNDROME; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; IN VITRO STUDY; PROPHYLAXIS; PURE RED CELL ANEMIA; THYMECTOMY; THYMOMA; TREATMENT OUTCOME;

AGAMMAGLOBULINEMIA; AGED; BONE MARROW; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RED-CELL APLASIA, PURE; STEM CELL FACTOR; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 77749340764     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2811     Document Type: Article

References (25)

1. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 111: 1010-1022, 2000.
2. Sawada K. [Pure red cell aplasia: clinical manifestations and treatment]. Rinsho Ketsueki 47: 1438-1445, 2006 (in Japanese).
3. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 17: 2280-2289, 1999.
4. Rosenow EC 3rd, Hurley BT. Disorders of the thymus. A review. Arch Intern Med 144: 763-770, 1984.
5. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56: 12-16, 2003.
6. Taniguchi T, Usami N, Kawaguchi K, Yokoi K. Good syndrome accompanied by pure red cell aplasia. Interact Cardiovasc Thorac Surg 9: 750-752, 2009.
7. Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 101: 532-540, 2003.
8. Rappold I, Ziegler BL, Kohler I, et al. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90: 111-125, 1997.
9. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142: 505-514, 2008.
10. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224, 1990.
11. Huang EJ, Nocka KH, Buck J, Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 3: 349-362, 1992.
12. Toksoz D, Zsebo KM, Smith KA, et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A 89: 7350-7354, 1992.
13. Brannan CI, Lyman SD, Williams DE, et al. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A 88: 4671-4674, 1991.
14. Flanagan JG, Chan DC, Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64: 1025-1035, 1991.
15. Broudy VC. Stem cell factor and hematopoiesis. Blood 90: 1345-1364, 1997.
16. Abkowitz JL, Hume H, Yancik SA, Bennett LG, Matsumoto AM. Stem cell factor serum levels may not be clinically relevant. Blood 87: 4017-4018, 1996.
17. Abkowitz JL, Sabo KM, Nakamoto B, et al. Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit. Blood 78: 2198-2202, 1991.
18. Gussetis ES, Peristeri J, Kitra V, Liakopoulou T, Kattamis A, Graphakos S. Clinical value of bone marrow cultures in childhood pure red cell aplasia. J Pediatr Hematol Oncol 20: 120-124, 1998.
19. Linenberger ML, Jacobson FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL. Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol 23: 1104-1114, 1995.
20. Beals CR, Clipstone NA, Ho SN, Crabtree GR. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 11: 824-834, 1997.
21. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 357: 2122-2128, 2001.
22. Fujimi A, Matsunaga T, Kobune M, et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol 87: 339-350, 2008.
23. Masuda M, Teramura M, Matsuda A, et al. Clonal T cells of pure red-cell aplasia. Am J Hematol 79: 332-333, 2005.
24. Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 9: 247-258, 2004.
25. Kang J, Der SD. Cytokine functions in the formative stages of a lymphocyte's life. Curr Opin Immunol 16: 180-190, 2004.